Article
Genotypic resistance tests for the management of patients with viro-immunological discordant response to highly active antiretroviral therapy.
Scandinavian journal of infectious diseases. Supplementum - 1 Jan 2003
Moroni Mauro
Abstract excerpt
Single withess: Drug resistance is one of the main factors limiting the success of antiretroviral therapy. Some other factors, such as individual enzymatic pattern and immune system function, play a role in the outcome of therapy in HIV infection. Moreover, adherence to treatment could also be a pivotal factor. Thus, there is a complex network that influences patients' response and ultimately contributes to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
